Bank of New York Mellon Corp - DEPOMED INC ownership

DEPOMED INC's ticker is DEPO and the CUSIP is 249908104. A total of 107 filers reported holding DEPOMED INC in Q4 2013. The put-call ratio across all filers is 0.66 and the average weighting 0.2%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of DEPOMED INC
ValueSharesWeighting
Q2 2018$4,818,000
+0.8%
722,363
-0.4%
0.00%0.0%
Q1 2018$4,778,000
-18.8%
725,195
-0.8%
0.00%
-50.0%
Q4 2017$5,883,000
+35.1%
730,783
-2.8%
0.00%
+100.0%
Q3 2017$4,356,000
-45.7%
752,162
+0.7%
0.00%
-50.0%
Q2 2017$8,020,000
-17.4%
746,738
-3.5%
0.00%
-33.3%
Q1 2017$9,709,000
-29.6%
773,571
+1.0%
0.00%
-25.0%
Q4 2016$13,799,000
-35.9%
765,799
-11.1%
0.00%
-33.3%
Q3 2016$21,521,000
+38.3%
861,888
+8.7%
0.01%
+20.0%
Q2 2016$15,560,000
+31.3%
793,055
-6.8%
0.01%
+25.0%
Q1 2016$11,851,000
-38.3%
850,681
-19.7%
0.00%
-33.3%
Q4 2015$19,198,000
-4.7%
1,058,960
-0.9%
0.01%0.0%
Q3 2015$20,145,000
-1.8%
1,068,717
+11.8%
0.01%0.0%
Q2 2015$20,520,000
-2.6%
956,133
+1.7%
0.01%
+20.0%
Q1 2015$21,073,000
+81.1%
940,338
+30.2%
0.01%
+66.7%
Q4 2014$11,635,000
+14.8%
722,274
+8.3%
0.00%0.0%
Q3 2014$10,132,000
+14.4%
667,115
+4.7%
0.00%
+200.0%
Q2 2014$8,856,000
+93.5%
637,152
+101.8%
0.00%0.0%
Q1 2014$4,577,000
+23.9%
315,659
-9.6%
0.00%0.0%
Q4 2013$3,693,000
-29.7%
349,113
-50.4%
0.00%0.0%
Q3 2013$5,256,000
+170.5%
703,852
+103.6%
0.00%0.0%
Q2 2013$1,943,000345,6650.00%
Other shareholders
DEPOMED INC shareholders Q4 2013
NameSharesValueWeighting ↓
DELTEC ASSET MANAGEMENT LLC 2,252,402$31,376,0007.88%
Healthcare Value Capital, LLC 350,000$4,876,0007.16%
Senvest Management, LLC 4,977,256$69,333,0005.82%
Consonance Capital Management LP 2,756,360$38,396,0005.81%
Opaleye Management Inc. 325,000$4,527,0002.82%
Krensavage Asset Management, LLC 447,000$6,227,0002.23%
Healthcare Value Capital, LLC 100,000$1,393,0002.05%
Starboard Value LP 2,950,000$41,094,0001.44%
HealthInvest Partners AB 200,000$2,786,0001.30%
OAK RIDGE INVESTMENTS LLC 7,206,286$100,384,0001.29%
View complete list of DEPOMED INC shareholders